The Enterprise Value as of June 2026 (TTM) for Carisma Therapeutics, Inc. (CARM) is -1759745.00

According to Carisma Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1759745.00. This represents a change of -120.13% compared to the average of 8.74M of the last 4 quarters.

Carisma Therapeutics, Inc. (CARM) Historical Enterprise Value (quarterly & annually)

How has CARM Enterprise Value performed in the past?

The mean historical Enterprise Value of Carisma Therapeutics, Inc. over the last ten years is 76.27M. The current -1759745.00 Enterprise Value has changed -330.73% with respect to the historical average. Over the past ten years (40 quarters), CARM's Enterprise Value was at its highest in in the June 2021 quarter at 659.31M. The Enterprise Value was at its lowest in in the March 2022 quarter at -49615350.00.

Carisma Therapeutics, Inc. (CARM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Carisma Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Carisma Therapeutics, Inc. (CARM) Average Enterprise Value

How has CARM Enterprise Value performed in the past?

The current Enterprise Value of Carisma Therapeutics, Inc. (CARM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Carisma Therapeutics, Inc. (CARM) Enterprise Value vs. Peers

How is CARM’s Enterprise Value compared to its peers?

Carisma Therapeutics, Inc.’s Enterprise Value is greater than Jasper Therapeutics, Inc. (-5949824.00), greater than Onconetix, Inc. (-3085440.00), greater than Enveric Biosciences, Inc. (-3995341.00), greater than SciSparc Ltd. (-3730477.00), less than Silexion Therapeutics Ltd. (-665546.00), greater than Salarius Pharmaceuticals, Inc. (-4623480.00), greater than Revelation Biosciences, Inc. (-9460412.00), less than CDT Equity Inc. (1.08B), less than Indaptus Therapeutics, Inc. (4.77M), greater than Aspire Biopharma Holdings, Inc. (-4785565.00),

Build a custom stock screener for Carisma Therapeutics, Inc. (CARM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carisma Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carisma Therapeutics, Inc. (CARM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carisma Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.